126 related articles for article (PubMed ID: 15318183)
1. Firm sets sights on gene silencing to protect vision.
Check E
Nature; 2004 Aug; 430(7002):819. PubMed ID: 15318183
[No Abstract] [Full Text] [Related]
2. Hopes rise for RNA therapy as mouse study hits target.
Check E
Nature; 2004 Nov; 432(7014):136. PubMed ID: 15538330
[No Abstract] [Full Text] [Related]
3. Silence is golden: can RNA interference therapeutics deliver?
Beal J
Drug Discov Today; 2005 Feb; 10(3):169-72. PubMed ID: 15708529
[No Abstract] [Full Text] [Related]
4. Vision. Changes as you age.
Mayo Clin Health Lett; 2003 Jun; Suppl():1-8. PubMed ID: 12793371
[No Abstract] [Full Text] [Related]
5. Therapeutic possibilities of interference RNA.
López Tricas JM
Farm Hosp; 2012; 36(3):115-7. PubMed ID: 22137610
[No Abstract] [Full Text] [Related]
6. A crucial test.
Check E
Nat Med; 2005 Mar; 11(3):243-4. PubMed ID: 15746929
[No Abstract] [Full Text] [Related]
7. RNA interference and potential therapeutic applications of short interfering RNAs.
Karagiannis TC; El-Osta A
Cancer Gene Ther; 2005 Oct; 12(10):787-95. PubMed ID: 15891770
[TBL] [Abstract][Full Text] [Related]
8. Genetics. First gene for severe dry macular degeneration.
Kaiser J
Science; 2008 Aug; 321(5893):1146-7. PubMed ID: 18755949
[No Abstract] [Full Text] [Related]
9. LOC387715, smoking and their prognostic impact on visual functional status in age-related macular degeneration-The Muenster Aging and Retina Study (MARS) cohort.
Neuner B; Wellmann J; Dasch B; Dietzel M; Farwick A; Stoll M; Pauleikhoff D; Hense HW
Ophthalmic Epidemiol; 2008; 15(3):148-54. PubMed ID: 18569809
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of age-related macular degeneration.
Tezel TH; Bora NS; Kaplan HJ
Trends Mol Med; 2004 Sep; 10(9):417-20. PubMed ID: 15350892
[No Abstract] [Full Text] [Related]
11. RNA therapy beckons as firms prepare for clinical trials.
Check E
Nature; 2004 Jun; 429(6994):792. PubMed ID: 15215824
[No Abstract] [Full Text] [Related]
12. Vision rehabilitation and AMD.
Colenbrander A; Goodwin L; Fletcher DC
Int Ophthalmol Clin; 2007; 47(1):139-48. PubMed ID: 17237678
[No Abstract] [Full Text] [Related]
13. Outcome measures to assess efficacy of treatments for age-related macular degeneration.
Wittes J; Downs M
Ophthalmology; 2009 Oct; 116(10 Suppl):S8-14. PubMed ID: 19800537
[TBL] [Abstract][Full Text] [Related]
14. Macular degeneration: recent advances and therapeutic opportunities.
Rattner A; Nathans J
Nat Rev Neurosci; 2006 Nov; 7(11):860-72. PubMed ID: 17033682
[TBL] [Abstract][Full Text] [Related]
15. Visual results with low-vision aids in age-related macular degeneration.
Archambault P; Colenbrander A
Am J Ophthalmol; 1989 May; 107(5):564-6. PubMed ID: 2712148
[No Abstract] [Full Text] [Related]
16. Interference RNA technology in the treatment of CNV.
Tolentino M
Ophthalmol Clin North Am; 2006 Sep; 19(3):393-9, vi-vii. PubMed ID: 16935214
[TBL] [Abstract][Full Text] [Related]
17. Macular degeneration: looking age in the eye.
Harv Mens Health Watch; 2001 Jul; 5(12):4-8. PubMed ID: 11511460
[No Abstract] [Full Text] [Related]
18. Senile macular degeneration in northern India.
Jain IS; Prasad P; Gupta A; Ram J; Dhir SP
Indian J Ophthalmol; 1984; 32(5):343-6. PubMed ID: 6545319
[No Abstract] [Full Text] [Related]
19. Wandering eye for RNAi.
Rossi J; Zamore P; Kay MA
Nat Med; 2008 Jun; 14(6):611. PubMed ID: 18535575
[No Abstract] [Full Text] [Related]
20. Maculas, monkeys, models, AMD and aging.
Dawson WW; Dawson JC; Lake KP; Gonzalez-Martinez J
Vision Res; 2008 Feb; 48(3):360-5. PubMed ID: 17892891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
